Picture of Sage Therapeutics logo

SAGE Sage Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Annual cashflow statement for Sage Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-680606-458-533-541
Depreciation
Non-Cash Items14395.3946666.9
Other Non-Cash Items
Changes in Working Capital6.66-39.7-18.55.67-67.4
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-529664-378-460-541
Capital Expenditures-5.75-0.345-0.372-0.937-0.553
Purchase of Fixed Assets
Other Investing Cash Flow Items-137443-1,002326443
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-143443-1,002325443
Financing Cash Flow Items-2.5-1.39-0.043-0.903
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities60842713.33.076.03
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-64.21,534-1,367-132-91.6